Similar Articles
711 Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
712 Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
713 Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
714 Left colonic metastasis from primary hepatocellular carcinoma: A case report
715 Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
716 Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?
717 Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis
718 Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
719 Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells
720 Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA